| ncRNA name | hsa-miR-210 |
| ncRNA Category | miRNA |
| Disease name | von Hippel-Lindau disease |
| Species | Homo sapiens |
| Tissues/Cell_line | blood |
| Methods | qRT-PCR |
| Expression pattern | associated |
| Functional description | Mir210 is a micro-RNA responsive to hypoxia that we have used as a new putative biomarker to follow VHL patient evolution during the clinical trial. |
| PubMed ID | 28662711 |
| Year | 2017 |
| Title | Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.